Radius Health

CompanyUnited States

Radius Health develops one asset, approved (abaloparatide in fractures). Mostly peptide acting on PTH1R; based in the United States.

Assets
1
Furthest
Approved
Trials
7
Signals
0

Pipeline

1

  • abaloparatide

    PTH1 receptor agonist that stimulates bone formation

    ApprovedPeptidePTH1Rfracturesosteoporosis

Full company profiles: pipeline, trials, funding and people.

See Pro
  • Evidence behind the mechanisms1
  • Trials10
  • Similar companies6

Updated 7 Oct 2026 · 15 sources

Intelligence